Interventions of Bioinformatics, AI, Diagnostics and Cancer Research
DOI:
https://doi.org/10.47611/jsrhs.v13i3.6966Keywords:
Bioinformatics, AI, Cancer, Nanotechnology, Global Health, ML, TheranosticsAbstract
The growing usage of nanotechnology has left a great impact on oncology by increasing efficiency and flexibility with patients and cancer types. Previous research has proven new ways to utilize nanotechnology to assist in diagnostics and treatment. AI and ML, Biomarkers, and biomedical engineering of biopsies and other forms of diagnosis have been made to aid in treating large populations. These new forms of cancer research are being implemented by more researchers and medical professionals, and have the potential to be used globally to decrease the mortality rate of cancer. This publication will focus on the adaptations of artificial intelligence, usages of biomarkers, implementations of nano and biotechnology, the ability to target and treat cancer, and point-of-care diagnostics to study the global impact of interventions of cancer.
Downloads
References or Bibliography
Al Kez, Dlzar, et al. "Energy poverty assessment: Indicators and implications for developing and developed countries." Energy Conversion and Management 307 (2024): 118324.
Diamandis, Eleftherios P. "Present and future of cancer biomarkers." Clinical Chemistry and Laboratory Medicine (CCLM) 52.6 (2014): 791-794.
Hayes, Bryony, et al. "Developments in point-of-care diagnostic technology for cancer detection." Diagnostics 8.2 (2018): 39.
Hunter, Benjamin, Sumeet Hindocha, and Richard W. Lee. "The role of artificial intelligence in early cancer diagnosis." Cancers 14.6 (2022): 1524.
Kumar, S., A. Mohan, and R. Guleria. "Biomarkers in cancer screening, research and detection: present and future: a review." Biomarkers 11.5 (2006): 385-405.
Lakhani, Hari Vishal, et al. "Detecting early onset of anthracyclines-induced cardiotoxicity using a novel panel of biomarkers in West-Virginian population with breast cancer." Scientific Reports 11.1 (2021): 7954.
Mantula, Fennie, Yoesrie Toefy, and Vikash Sewram. "Barriers to cervical cancer screening in Africa: a systematic review." BMC Public Health 24.1 (2024): 525.
Moten, Asad, Daniel Schafer, and Mauro Ferrari. "Redefining global health priorities: Improving cancer care in developing settings." Journal of global health 4.1 (2014).
Nakamura, Kota, et al. "A liquid biopsy signature for the detection of patients with early-onset colorectal cancer." Gastroenterology 163.5 (2022): 1242-1251.
Pramesh, C. S., et al. "Priorities for cancer research in low-and middle-income countries: a global perspective." Nature medicine 28.4 (2022): 649-657.
Pui, Ching-Hon, ed. Treatment of acute leukemias: new directions for clinical research. Springer Science & Business Media, 2002.
Sargazi, Saman, et al. "Recent trends in mesoporous silica nanoparticles of rode-like morphology for cancer theranostics: A review." Journal of Molecular Structure 1261 (2022): 132922.
Soni, Ambikesh, et al. "Nano‐biotechnology in tumour and cancerous disease: A perspective review." Journal of Cellular and Molecular Medicine 27.6 (2023): 737-762.
Wang, Ping, et al. "Early detection of lung cancer in serum by a panel of microRNA biomarkers." Clinical lung cancer 16.4 (2015): 313-319.
Published
How to Cite
Issue
Section
Copyright (c) 2024 Avyukta Tatta
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
Copyright holder(s) granted JSR a perpetual, non-exclusive license to distriute & display this article.
